BCPC (Balchem) 5-Year EBITDA Growth Rate: 9.40% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BCPC Balchem Corp BCPC
94 GF Score
Price $162.97
GF Value $177.97
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Balchem 5-Year EBITDA Growth Rate?

Balchem BCPC -0.23% 94 5-Year EBITDA Growth Rate is 9.40% as of Mar. 2026. GuruFocus rates BCPC with a GF Score™ of 94/100 and a GF Value™ of $177.97 (Fairly Valued). The stock has 1 warning sign investors should review.

Balchem's EBITDA per Share for the three months ended in Mar. 2026 was $2.08.

During the past 12 months, Balchem's average EBITDA Per Share Growth Rate was 10.90% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 8.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 9.40% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 6.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Balchem was 45.20% per year. The lowest was -2.30% per year. And the median was 14.20% per year.

Balchem  (NAS:BCPC) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Balchem 5-Year EBITDA Growth Rate Related Terms

BCPC vs PRM, SXT, CBT: 5-Year EBITDA Growth Rate Comparison

For the Specialty Chemicals subindustry, Balchem's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Balchem 5-Year EBITDA Growth Rate vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Balchem's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Balchem's 5-Year EBITDA Growth Rate falls into.


BCPC
94GF Score
Balchem Corp BCPC
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Balchem 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 9.40% mean?
Balchem (BCPC) has a 5-Year EBITDA Growth Rate of 9.40% as of Mar. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Balchem and its competitors.
Is Balchem's 5-Year EBITDA Growth Rate too high?
Balchem's current 5-Year EBITDA Growth Rate is 9.40%. Overall, Balchem has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Balchem's 5-Year EBITDA Growth Rate compare to PRM and SXT?
Balchem's 5-Year EBITDA Growth Rate of 9.40% can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Chemicals company?
A good 5-Year EBITDA Growth Rate depends on the Chemicals industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Balchem and its competitors. Balchem's current 5-Year EBITDA Growth Rate is 9.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Balchem stock overvalued right now?
Based on GuruFocus' analysis, Balchem (BCPC) is currently considered Fairly Valued. The stock's GF Value™ is $177.97, compared to a current price of $162.97 — trading 8.4% below its estimated fair value. The current 5-Year EBITDA Growth Rate is 9.40%. Balchem's overall GF Score™ is 94/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Balchem (BCPC), the current 5-Year EBITDA Growth Rate is 9.40% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Balchem (BCPC) Overvalued in 2026?

Based on GuruFocus' analysis, Balchem stock appears to be undervalued. The current stock price of $162.97 is trading 8.4% below its estimated GF Value™ of $177.97. GuruFocus considers Balchem to be Fairly Valued.

Key valuation signals for BCPC:

  • 5-Year EBITDA Growth Rate: 9.40%
  • GF Value™: $177.97 vs. price of $162.97 (8.4% below fair value)
  • GF Score™: 94/100 with 1 warning sign

No single metric tells the full story. See the BCPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Balchem Business Description

Other Exchanges BL9B:Germany
Address 5 Paragon Drive, Montvale, NJ, USA, 07645
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
94GF Score

Get the complete analysis for BCPC

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$162.97
Price
$177.97
GF Value